December 1, 2003
SEAIR Corporate Update
Edmonton, Alberta, December 1, 2003. SEAIR Inc. ("SDS" on the TSX Venture
Exchange) is pleased to announce it held its Annual General Meeting on November 28,
2003 and all corporate resolutions were passed. SEAIR also announces that Robert
Kinasewich has stepped down as President and Chief Executive Officer, and will remain
as a director of the company. Mr. Kinasewich indicated that he is very happy with the
management team that has been built thus allowing him to pursue other opportunities but
looks forward to an active role as a board member going forward. Mr. Kinasewich has
accomplished a number of key corporate objectives including the signing of key
distribution arrangements with Crofton Grower Services and Zwart Systems, an exclusive
marketing agreement with AirSep Corporation and revenue generation through the sale of
its nutrient diffusers to the greenhouse industry. SEAIR has initiated a search for a new
President and Chief Executive Officer, with Harold Kinasewich elevated to the position
of interim President and Chief Executive Officer.
SEAIR continues to market its nutrient diffusion technology to the greenhouse and
growing sectors, and intends to begin introducing its sterilization applications to
interested parties. The SEAIR sterilization technology uses 35% food grade hydrogen
peroxide and ozone diffused into water to produce an environmentally friendly sterilizing
agent with the only by-products being water, oxygen and carbon.
SEAIR is engaged in the development, manufacture and sales of its proprietary diffusion
and sterilization technologies with applications in various industries throughout North
America and globally. The Corporation is currently actively involved in the North
American Greenhouse industry within which it has been successful in the implementation
and sales of its greenhouse nutrient diffusion and oxygenation technology. Further
applications, such as aquaculture oxygenation, aquaponics oxygenation, an
environmentally benign sterilization process, bio-remediation system and an animal
enhancement oxygenation system are being developed and tested.
Parties interested in obtaining further information or receiving news releases and
corporate documents from SEAIR may e-mail such request to ir@boardmarker.net or
visit the SEAIR web site at: www.seair.ca .
FOR FURTHER INFORMATION PLEASE CONTACT:
Boardmarker Consultancy Group
T: 403 517 2270
F: 403 517 2289
E: ir@boardmarker.net
Harold Kinasewich
SEAIR Inc.
T: 780 477 7188
F: 780 477 6622
E: seair@telus.net
This News Release includes certain “forward-looking statement” as such term is commonly understood. There can be no
assurance that such statement will prove to be accurate. Actual results and future events could differ materially from those
anticipated in such statements. Readers are cautioned not to place undue reliance on these forward-looking statements that
speak only as of the date of this announcement. Important factors that could cause actual results to differ materially from the
Corporation’s expectations include, among others, the ongoing results of current search. All subsequent written and oral
forward-looking statements attributable to the Corporation or persons acting on its behalf are expressly qualified in their
entirety by this notice. While the Corporation anticipates that subsequent events and developments may cause the
Corporation’s views to change, the Corporation specifically disclaims any obligation to update these forward-looking
statements. These forward-looking statements should not be relied upon as representing the Corporation’s views as of any
date subsequent to the date of this release.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
